Navigation Links
Lotus Pharmaceuticals, Inc. Announces Conference Call to Discuss First Quarter 2008 Results
Date:5/27/2008

BEIJING, May 27 /Xinhua-PRNewswire-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) (''Lotus'' or the ''Company''), a pharmaceutical company in the People's Republic of China ("PRC"), today announced that it will conduct a conference call at 10:00 a.m. Eastern Time on Tuesday, May 27, 2008 to discuss the first quarter 2008 results.

Joining Mr. Zhongyi Liu, Chairman and Chief Executive Officer of Lotus Pharmaceuticals, will be Mr. Adam Wasserman, Chief Financial Officer.

To participate in the live conference call, please dial the following number five to ten minutes prior to the scheduled conference call time: 888-481-7939. International callers should dial 617-847-8707, Conference Passcode: 45954238.

If you are unable to participate in the call at this time, a replay will be available for seven days starting on May 27, at 11:00 a.m. Eastern Time. To access the replay, dial 888-286-8010, international callers dial 617-801-6888, and enter the passcode of 82020022.

About Lotus Pharmaceuticals, Inc.

Lotus Pharmaceuticals, Inc. (''Lotus'') controls and operates Liangfang Pharmaceutical, Ltd. (''Liangfang'') and Enze Jiashi Pharmaceutical, Ltd. (''En ze''), two Chinese pharmaceutical companies located in Beijing (together ''Lotus East''). Lotus East is a comprehensive enterprise, which deals in an integration of the production, trade, sales and marketing of pharmaceuticals. The Company possesses some of the most advanced pharmaceutical-production equipment used in China, workshops authenticated by the National GMP, a suite of various medicines produced by Lotus East, and a number of high-tech personnel. Lotus East has business and office facilities of 2,000 square meters, warehouse of 1,000 square meters and operates ten retail pharmacies in the Beijing area. Lotus East performs scientific research on new medicines, and the production, wholesale and retail sale of medicines through 10 retail pharmacy location t
'/>"/>

SOURCE Lotus Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Lotus Pharmaceuticals, Inc. Announces Resignation of Director Mel Rothberg
2. Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results
3. Lotus Pharmaceuticals, Inc. Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2007 Results
4. Lotus Pharmaceuticals Raises $5 Million in Private Placement
5. Lotus Pharmaceuticals, Inc. Implements Environmentally-friendly Cost Saving Strategies
6. Lotus Blossom Consulting Announces E-Book on Infertility Treatment Financing
7. Vista Partners Initiates Coverage on Alseres Pharmaceuticals, Inc. (Nasdaq: ALSE)
8. Alseres Pharmaceuticals, Inc. Reports First Quarter 2008 Operational and Financial Results
9. Alseres Pharmaceuticals, Inc. to Present at The Neurotech Industry Investing & Partnering Conference
10. Aida Pharmaceuticals, Inc. Announces Availability of Downloadable Corporate Synopsis on its Website
11. Aida Pharmaceuticals, Inc. Announces New Antibiotic Drug Under Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... Power Systems is proud to announce the sponsorship of ... is in his second year of racing in the professional ... Fire Department in Missoula, MT. He entered the triathlon scene ... career, he has had 15 1st Place finishes. In his ... in all seven of his 2014 races, including two 2nd ...
(Date:5/22/2015)... ZH Healthcare (ZH), ... today that Bill Lane, joins ZH’s Advisory Board. ... BlueEHS,a first of its kind, Freemium SaaS, Electronic ... Health Records (EHR) with an integrated practice management ... patient portal, and more. Combined with its Revenue ...
(Date:5/22/2015)... Hollywood, CA (PRWEB) May 22, 2015 ... at Sunset Plaza Dental announces that they are ... cosmetic, restorative and other dental treatments. At consultations, ... interest them. Questions regarding what certain treatments can ... also be covered during this initial appointment. If ...
(Date:5/22/2015)... NY (PRWEB) May 22, 2015 Medivo, Inc., ... “Positivity Rates and Genotype Results in ‘Baby Boomers’ Screened ... from a Nationwide Lab Test Database” at Digestive Disease Week, ... Medivo’s Clinical Affairs and Analytics team members Carol Smyth, MB; ... and Andrea Parker, MSI, along with Nancy Reau, MD from ...
(Date:5/22/2015)... 22, 2015 A Phase 3 ... American Society of Clinical Oncology (ASCO)’s annual meeting ... rates for those patients who received bevacizumab in ... pemetrexed/cisplatin. Bevacizumab (Avastin® Genentech, Inc.) is an antibody ... is already routinely used to treat many other ...
Breaking Medicine News(10 mins):Health News:ZH Healthcare Adds Bill Lane to Advisory Board 2Health News:West Hollywood Dental Office, Sunset Plaza Dental is Now Offering Complimentary Consultations 2Health News:Medivo Study Finds HCV Positivity Rates are 250% Higher Among Baby Boomers 2Health News:Mesothelioma Research Organization Excited About Imminent Improvement to Standard of Care 2
... 7 Vion,Pharmaceuticals, Inc. (Nasdaq Capital Market: VION) ... that the Company had regained,compliance with Marketplace Rule ... Stock had traded at $1.00 per share or ... Vion Pharmaceuticals, Inc. is committed to extending the ...
... MGT Capital Investments,Inc. (Amex: MGT ), ... ("HCIT") sector, today commented on the American Cancer,Society,s ... its colon cancer screening guidelines. MGT Capital Investment,s,Medicsight ... exchange under,"MDST," is an industry leader in the ...
... March 7 Novavax, Inc.,(Nasdaq: NVAX ) a ... and Chief Executive Officer, will be presenting at,the Partnering ... on March 11,2008 in Washington D.C. Dr. Singhvi will ... the area of vaccine development to,protect against H5N1 pandemic ...
... Calif., March 7 Genoptix, Inc.,(Nasdaq: GXDX ), ... in the 11th Annual Lehman Brothers Global,Health Care Conference ... Fla.,March 18 - 20, 2008., Dr. Tina Nova ... will present at the conference on Tuesday, March 18, ...
... to protect its Intellectual Property that, has been employed in Minimally Invasive ... ... decade, MARIETTA, Ga., March 7 In a much anticipated decision,Judge ... personally liable for expenses and attorneys,fees incurred by ERBE while defending against ...
... Liverpool School of Tropical Medicine has received a $30 million ... the control and treatment of malaria in pregnancy in Africa, ... directly benefit the 50 million women who face exposure to ... research at Liverpool and at 38 partner institutions in 27 ...
Cached Medicine News:Health News:Vion Pharmaceuticals Regains NASDAQ Listing Compliance 2Health News:MGT Comments on American Cancer Society's Decision to Endorse CT Colonography 2Health News:MGT Comments on American Cancer Society's Decision to Endorse CT Colonography 3Health News:MGT Comments on American Cancer Society's Decision to Endorse CT Colonography 4Health News:Genoptix Announces Participation at Lehman Brothers 11th Annual Global Health Care Conference 2Health News:ERBE Perseveres Yet Again in Opposition to Dr. Jerome Canady, and is Awarded More Than One Million Dollars 2Health News:LSTM to lead $30 million research program into malaria in pregnancy 2
(Date:5/21/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/6csvbs/market_assessment ... "Market Assessment of Respiratory Diagnostics in the United ... ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,This research service provides ... in the United States ... provides detailed analysis of the current and forecasted ...
(Date:5/21/2015)... , May 21, 2015  Cardica, Inc. (Nasdaq: ... employee Greg Watson , the company,s vice president of ... the company,s common stock, at a per share exercise price ... The stock option was granted pursuant to Cardica, Inc.,s Inducement ... in May 2015 under Rule 5653(c)(4) of the Nasdaq Global ...
(Date:5/21/2015)... 21. Mai 2015 Dipexium ... ein Unternehmen für Arzneimittel im fortgeschrittenen ... und Vermarktung von Locilex® (Pexiganan-Creme 0,8 %) ... eine wissenschaftliche Posterpräsentation an, welche das ... vorstellt, OneStep-1 und OneStep-2, in der ...
Breaking Medicine Technology:United States and Europe Respiratory Diagnostics Market Assessment 2015 2Cardica Announces New Employment Inducement Grant 2Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 2Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 3Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 4Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 5Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 6Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 7
... gloves were designed with the surgeon in ... protection, and value. It offers comfort and ... dry hands. The broader, anatomical design allows ... surface offers sensitivity and an effective grip, ...
The Next Generation in Operating Room Equipment and Management Solutions is here Today. NuBoom is a self-contained, pedestal-mounted boom that houses medical, audio and visual equipment....
... versatility and positioning, look to BERCHTOLD's OPERON ... design and 770 lb. weight capacity ensures ... specialties and patient sizes. The radiolucent phenolic ... with a C-arm. An intuitive remote control ...
... is a new product number, ... product number. If showing no ... the old Sigma-Aldrich number (Z37,158-0) ... assistance. Color: colour-coded ...
Medicine Products: